Oct 21 (Reuters) - Abbott Laboratories posted a
28.3% rise in third-quarter profit on Wednesday, helped by
strong sales of COVID-19 tests and strength in its nutrition and
The company's net earnings rose to $1.23 billion, or 69
cents per share, in the quarter ended Sept. 30, from $960
million, or 53 cents per share, a year earlier.
(Reporting by Manojna Maddipatla and Trisha Roy in Bengaluru;
Editing by Arun Koyyur)